Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

This week, Bobbi Conner talks with Dr. Rachel Kaplan about managing atrial fibrillation. Dr. Kaplan is an Associate Professor ...

Please provide your email address to receive an email when new articles are posted on . An updated guideline on the prevention and management of atrial fibrillation includes a new staging system to ...

The risk for dementia goes up in patients with atrial fibrillation (AF), but some evidence suggests that risk can be blunted with therapies that restore sinus rhythm. But a new cohort study suggests ...

In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure and even premature death. While many risk factors contribute to A-fib, one stands ...

Please provide your email address to receive an email when new articles are posted on . A novel SK ion channel inhibitor more often converted atrial fibrillation to sinus rhythm compared with placebo.

ST. LOUIS — Dr. Paban Saha, an Electrophysiologist with Prairie Cardiovascular, discusses atrial fibrillation. What is Atrial Fibrillation (A-fib)? A-fib is a common heart condition where the heart ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Sign up for CNN’s Sleep, But Better newsletter series. Our seven-part guide has helpful hints to achieve better sleep. About 1 in 4 women may experience irregular ...